The global burden of chromoblastomycosis
Daniel Wagner de Castro Lima Santos(D’Or Institute for Research and Education), Arnaldo Lopes Colombo(Universidade Federal de São Paulo), Anderson Messias Rodrigues(Universidade Federal de São Paulo), Flávio Queiroz‐Telles(Hospital de Clínicas Universidade Federal do Paraná), David W. Denning(Manchester Academic Health Science Centre), Sybren de Hoog(Radboud University Nijmegen), Vânia Aparecida Vicente(Universidade Federal do Paraná), Conceição de Maria Pedrozo e Silva de Azevedo(Universidade Federal do Maranhão)
Cited by 105
Related Papers
Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for <i>Fungi</i>
|Proceedings of the National Academy of Sciences|2012|5.1k
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
|Journal of Fungi|2017|2.9k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k